The 2.5 mg starting dose translates to a specific number of units depending on your compounded tirzepatide concentration
Follow-up timing varies by centre but commonly occurs at around six weeks, three months, six months, and twelve months post-surgery
Calocurb should not be taken by individuals that have any form of gastrointestinal inflammation or inflammatory bowel disease, such as Crohn's or ulcerative colitis
doi: 10.1158/1541-7786.MCR-20-0570 151 HardingJJTelliMLMunsterPNLeMHMolineauxCBennettMKet al
Studies have shown that the NLRP3 inflammasome is also involved in other skin diseases, such as psoriasis, urticaria, and bullous pemphigoid (179)
doi: 10.1007/s00125-013-2841-0 32 CalannaSChristensenMHolstJJLaferrreBGluudLLVilsbllTet al